[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1053788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 858245, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gordon Bruce Dunn J.D.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 433620, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.7, "open": 6.7, "dayLow": 6.67, "dayHigh": 6.82, "regularMarketPreviousClose": 6.7, "regularMarketOpen": 6.7, "regularMarketDayLow": 6.67, "regularMarketDayHigh": 6.82, "payoutRatio": 0.0, "beta": 1.846, "forwardPE": -5.6363635, "volume": 3183, "regularMarketVolume": 3183, "averageVolume": 174927, "averageVolume10days": 5150, "averageDailyVolume10Day": 5150, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 4011299, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 54.95, "fiftyDayAverage": 8.66298, "twoHundredDayAverage": 13.85925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 131616472, "profitMargins": 0.0, "floatShares": 4128079, "sharesOutstanding": 588167, "sharesShort": 9152, "sharesShortPriorMonth": 34696, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0156, "heldPercentInsiders": 0.07077, "heldPercentInstitutions": 0.06855, "shortRatio": 1.28, "shortPercentOfFloat": 0.069299996, "impliedSharesOutstanding": 20585800, "bookValue": 10.075, "priceToBook": 0.6769231, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -10447371, "trailingEps": -34.62, "forwardEps": -1.21, "lastSplitFactor": "1:35", "lastSplitDate": 1744156800, "enterpriseToEbitda": -12.045, "52WeekChange": -0.65204084, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 6.82, "targetHighPrice": 350.00034, "targetLowPrice": 30.0, "targetMeanPrice": 150.00012, "targetMedianPrice": 70.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 11552720, "totalCashPerShare": 0.561, "ebitda": -10927358, "totalDebt": 2773733, "quickRatio": 2.379, "currentRatio": 2.574, "debtToEquity": 46.808, "returnOnAssets": -0.47404, "returnOnEquity": -1.38823, "freeCashflow": -5216705, "operatingCashflow": -9017116, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "regularMarketChangePercent": 1.7910503, "regularMarketPrice": 6.82, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "postMarketChangePercent": -2.93256, "postMarketPrice": 6.62, "postMarketChange": -0.2, "regularMarketChange": 0.12000036, "regularMarketDayRange": "6.67 - 6.82", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 174927, "fiftyTwoWeekLowChange": 1.81, "fiftyTwoWeekLowChangePercent": 0.36127743, "fiftyTwoWeekRange": "5.01 - 54.95", "fiftyTwoWeekHighChange": -48.13, "fiftyTwoWeekHighChangePercent": -0.87588716, "fiftyTwoWeekChangePercent": -65.20409, "dividendDate": 1571788800, "earningsTimestamp": 1747137603, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -34.62, "epsForward": -1.21, "epsCurrentYear": -17.50002, "priceEpsCurrentYear": -0.38971388, "fiftyDayAverageChange": -1.8429799, "fiftyDayAverageChangePercent": -0.21274202, "twoHundredDayAverageChange": -7.03925, "twoHundredDayAverageChangePercent": -0.5079099, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cellect Biotechnology Ltd.", "nameChangeDate": "2025-07-27", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754079003, "regularMarketTime": 1754078400, "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]